An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Clinical trial NCT02560766 · UNKNOWN
Trial details
- NCT number
- NCT02560766
- Sponsor
- XenoPort, Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2023-10-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.